<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35072927</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1720-8386</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>45</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of endocrinological investigation</Title>
          <ISOAbbreviation>J Endocrinol Invest</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Testosterone positively regulates vagina NO-induced relaxation: an experimental study in rats.</ArticleTitle>
        <Pagination>
          <StartPage>1161</StartPage>
          <EndPage>1172</EndPage>
          <MedlinePgn>1161-1172</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s40618-022-01743-4</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Female sexual response involves a complex interplay between neurophysiological mechanisms and the nitric oxide (NO)-mediated relaxation of clitoris and vagina. The aim of this study was to evaluate sex steroids regulation of the relaxant pathway in vagina, using a validated animal model.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Subgroups of OVX Sprague-Dawley rats were treated with 17β-estradiol, testosterone, or testosterone and letrozole, and compared with a group of intact animals. Masson's trichrome staining was performed for morphological evaluation of the distal vaginal wall, in vitro contractility studies investigated the effect of OVX and in vivo treatments on vaginal smooth muscle activity. RNA from vaginal tissue was analyzed by semi-quantitative RT-PCR.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Immunohistochemical analysis showed that OVX induced epithelial and smooth muscle structural atrophy, testosterone and testo + letrozole increased the muscle bundles content and organization without affecting the epithelium while 17β-estradiol mediated the opposite effects. In vitro contractility studies were performed on noradrenaline pre-contracted vaginal strips from each experimental group. Acetylcholine (0.001-10 µM) stimulation induced a concentration-dependent relaxation, significantly reduced by NO-synthase inhibitor L-NAME and by guanylate cyclase inhibitor ODQ. OVX resulted in a decreased responsiveness to acetylcholine, restored by testosterone, with or without letrozole, but not by 17β-estradiol. OVX sensitivity to the NO-donor SNP was higher than in the control. Vardenafil, a PDE5 inhibitor, enhanced SNP effect in OVX + testosterone as well as in control, as supported by RNA expression analysis.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study demonstrates that testosterone improves the NO-mediated smooth muscle vaginal cells relaxation confirming its role in maintaining the integrity of muscular relaxant machinery.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cellai</LastName>
            <ForeName>I</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Andrology, Women's Endocrinology and Gender Incongruence Unit, Department of Excellence Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Pieraccini 6, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Filippi</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Interdepartmental Laboratory of Functional and Cellular Pharmacology of Reproduction, Department of Neurosciences, Drug Research and Child Health (NEUROFARBA), University of Florence, Viale Pieraccini 6, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Comeglio</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Andrology, Women's Endocrinology and Gender Incongruence Unit, Department of Excellence Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Pieraccini 6, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cipriani</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Andrology, Women's Endocrinology and Gender Incongruence Unit, Department of Excellence Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Pieraccini 6, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maseroli</LastName>
            <ForeName>E</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Andrology, Women's Endocrinology and Gender Incongruence Unit, Department of Excellence Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Pieraccini 6, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Di Stasi</LastName>
            <ForeName>V</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Andrology, Women's Endocrinology and Gender Incongruence Unit, Department of Excellence Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Pieraccini 6, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Todisco</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Andrology, Women's Endocrinology and Gender Incongruence Unit, Department of Excellence Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Pieraccini 6, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marchiani</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Andrology, Women's Endocrinology and Gender Incongruence Unit, Department of Excellence Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Pieraccini 6, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tamburrino</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Villanelli</LastName>
            <ForeName>F</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Endocrinology Unit, Department of Excellence Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Pieraccini 6, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vezzani</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Andrology, Women's Endocrinology and Gender Incongruence Unit, Department of Excellence Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Pieraccini 6, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Corno</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Andrology, Women's Endocrinology and Gender Incongruence Unit, Department of Excellence Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Pieraccini 6, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fambrini</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Obstetrics and Gynecology, Department of Excellence Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni 50, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guarnieri</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sarchielli</LastName>
            <ForeName>E</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Morelli</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rastrelli</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Andrology, Women's Endocrinology and Gender Incongruence Unit, Department of Excellence Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Pieraccini 6, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maggi</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Endocrinology Unit, Department of Excellence Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Pieraccini 6, 50134, Florence, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>I.N.B.B. (Istituto Nazionale Biostrutture e Biosistemi), Viale delle Medaglie d'Oro 305, 00136, Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vignozzi</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0003-0907-0630</Identifier>
            <AffiliationInfo>
              <Affiliation>Andrology, Women's Endocrinology and Gender Incongruence Unit, Department of Excellence Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Pieraccini 6, 50134, Florence, Italy. linda.vignozzi@unifi.it.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>I.N.B.B. (Istituto Nazionale Biostrutture e Biosistemi), Viale delle Medaglie d'Oro 305, 00136, Rome, Italy. linda.vignozzi@unifi.it.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Endocrinol Invest</MedlineTA>
        <NlmUniqueID>7806594</NlmUniqueID>
        <ISSNLinking>0391-4097</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>31C4KY9ESH</RegistryNumber>
          <NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>3XMK78S47O</RegistryNumber>
          <NameOfSubstance UI="D013739">Testosterone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>4TI98Z838E</RegistryNumber>
          <NameOfSubstance UI="D004958">Estradiol</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>63231-63-0</RegistryNumber>
          <NameOfSubstance UI="D012313">RNA</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>7LKK855W8I</RegistryNumber>
          <NameOfSubstance UI="D000077289">Letrozole</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>N9YNS0M02X</RegistryNumber>
          <NameOfSubstance UI="D000109">Acetylcholine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000109" MajorTopicYN="Y">Acetylcholine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004958" MajorTopicYN="N">Estradiol</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000077289" MajorTopicYN="N">Letrozole</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009569" MajorTopicYN="Y">Nitric Oxide</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010052" MajorTopicYN="N">Ovariectomy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014621" MajorTopicYN="N">Vagina</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Estradiol</Keyword>
        <Keyword MajorTopicYN="N">Nitric oxide</Keyword>
        <Keyword MajorTopicYN="N">Ovariectomy</Keyword>
        <Keyword MajorTopicYN="N">Smooth muscle</Keyword>
        <Keyword MajorTopicYN="N">Testosterone</Keyword>
        <Keyword MajorTopicYN="N">Vagina</Keyword>
      </KeywordList>
      <CoiStatement>IC, SF, PC, SC, EM, VDS, TT, SM, LT, FV, SV, CC, MF, GG, ES, AM, GR, MM and LV declare that they have no relevant financial or non-financial interests to disclose.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>24</Day>
          <Hour>12</Hour>
          <Minute>15</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35072927</ArticleId>
        <ArticleId IdType="pmc">PMC9098587</ArticleId>
        <ArticleId IdType="doi">10.1007/s40618-022-01743-4</ArticleId>
        <ArticleId IdType="pii">10.1007/s40618-022-01743-4</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Davis SR, Wahlin-Jacobsen S. Testosterone in women—the clinical significance. Lancet Diabetes Endocrinol. 2015;3:980–992. doi: 10.1016/S2213-8587(15)00284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2213-8587(15)00284</ArticleId>
            <ArticleId IdType="pubmed">26358173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simon JA, Goldstein I, Kim NN, Davis SR, Kellogg-Spadt S, Lowenstein L, Pinkerton JV, Stuenkel CA, Traish AM, Archer DF, Bachmann G, Goldstein AT, Nappi RE, Vignozzi L. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review. Menopause. 2018;25:837–847. doi: 10.1097/GME.0000000000001138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/GME.0000000000001138</ArticleId>
            <ArticleId IdType="pubmed">29870471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab. 2005;90:5226–5233. doi: 10.1210/jc.2004-1747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2004-1747</ArticleId>
            <ArticleId IdType="pubmed">16014407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis SR, Goldstat R, Papalia MA, Shah S, Kulkarni J, Donath S, Bell RJ. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial. Menopause. 2006;13:37–45. doi: 10.1097/01.gme.0000168061.32917.83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.gme.0000168061.32917.83</ArticleId>
            <ArticleId IdType="pubmed">16607097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panay N, Al-Azzawi F, Bouchard C, Davis SR, Eden J, Lodhi I, Rees M, Rodenberg CA, Rymer J, Schwenkhagen A, Sturdee DW. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric. 2010;13:121–131. doi: 10.3109/13697131003675922.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/13697131003675922</ArticleId>
            <ArticleId IdType="pubmed">20166859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panjari M, Davis SR. Vaginal DHEA to treat menopause related atrophy: a review of the evidence. Maturitas. 2011;70:22–25. doi: 10.1016/j.maturitas.2011.06.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.maturitas.2011.06.005</ArticleId>
            <ArticleId IdType="pubmed">21733647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Archer DF. Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy. J Steroid Biochem Mol Biol. 2015;145:139–143. doi: 10.1016/j.jsbmb.2014.09.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jsbmb.2014.09.003</ArticleId>
            <ArticleId IdType="pubmed">25201455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cellai I, Di Stasi V, Comeglio P, Maseroli E, Todisco T, Corno C, Filippi S, Cipriani S, Sorbi F, Fambrini M, Petraglia F, Scavello I, Rastrelli G, Acciai G, Villanelli F, Danza G, Sarchielli E, Guarnieri G, Morelli A, Maggi M, Vignozzi L. Insight on the intracrinology of menopause: androgen production within the human vagina. Endocrinology. 2021;162(2):bqaa219. doi: 10.1210/endocr/bqaa219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/endocr/bqaa219</ArticleId>
            <ArticleId IdType="pubmed">33247714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maseroli E, Cellai I, Filippi S, Comeglio P, Cipriani S, Rastrelli G, Rosi M, Sorbi F, Fambrini M, Petraglia F, Amoriello R, Ballerini C, Lombardelli L, Piccinni MP, Sarchielli E, Guarnieri G, Morelli A, Maggi M, Vignozzi L. Anti-inflammatory effects of androgens in the human vagina. J Mol Endocrinol. 2020;65:109–124. doi: 10.1530/JME-20-0147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/JME-20-0147</ArticleId>
            <ArticleId IdType="pubmed">32755990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burnett AL, Calvin DC, Silver RI, Peppas DS, Docimo SG. Immunohistochemical description of nitric oxide synthase isoforms in human clitoris. J Urol. 1997;158:75–78. doi: 10.1097/00005392-199707000-00020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00005392-199707000-00020</ArticleId>
            <ArticleId IdType="pubmed">9186326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cellek S, Moncada S. Nitrergic neurotransmission mediates the non-adrenergic non-cholinergic responses in the clitoral corpus cavernosum of the rabbit. Br J Pharmacol. 1998;125:1627–1629. doi: 10.1038/sj.bjp.0702278.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjp.0702278</ArticleId>
            <ArticleId IdType="pmc">PMC1565765</ArticleId>
            <ArticleId IdType="pubmed">9886752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vemulapalli S, Kurowski S. Sildenafil relaxes rabbit clitoral corpus cavernosum. Life Sci. 2000;67:23–29. doi: 10.1016/s0024-3205(00)00596-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0024-3205(00)00596-8</ArticleId>
            <ArticleId IdType="pubmed">10896025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park JK, Kim JU, Lee SO, Hwang PH, Yi HK, Kim YG, Cho KW. Nitric oxide cyclic GMP signaling pathway in the regulation of rabbit clitoral cavernosum tone. Exp Biol Med (Maywood) 2002;227:1022–1030. doi: 10.1177/153537020222701111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/153537020222701111</ArticleId>
            <ArticleId IdType="pubmed">12486213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park K, Moreland RB, Goldstein I, Atala A, Traish A. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle. Biochem Biophys Res Commun. 1998;249:612–617. doi: 10.1006/bbrc.1998.9206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/bbrc.1998.9206</ArticleId>
            <ArticleId IdType="pubmed">9731184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>D'Amati G, di Gioia CR, Bologna M, Giordano D, Giorgi M, Dolci S, Jannini EA. Type 5 phosphodiesterase expression in the human vagina. Urology. 2002;60:191–195. doi: 10.1016/s0090-4295(02)01663-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0090-4295(02)01663-1</ArticleId>
            <ArticleId IdType="pubmed">12100961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ückert S, Ellinghaus P, Albrecht K, Jonas U, Oelke M. Expression of messenger ribonucleic acid encoding for phosphodiesterase isoenzymes in human female genital tissues. J Sex Med. 2007;4:1604–1609. doi: 10.1111/j.1743-6109.2007.00595.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1743-6109.2007.00595.x</ArticleId>
            <ArticleId IdType="pubmed">17888073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ückert S, Oelke M, Albrecht K, Breitmeier D, Kuczyk MA, Hedlund P. Expression and distribution of key enzymes of the cyclic GMP signaling in the human clitoris: relation to phosphodiesterase type 5 (PDE5) Int J Impot Res. 2011;23:206–212. doi: 10.1038/ijir.2011.29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ijir.2011.29</ArticleId>
            <ArticleId IdType="pubmed">21697861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Comeglio P, Cellai I, Filippi S, Corno C, Corcetto F, Morelli A, Maneschi E, Maseroli E, Mannucci E, Fambrini M, Maggi M, Vignozzi L. Differential effects of testosterone and estradiol on clitoral function: an experimental study in rats. J Sex Med. 2016;13:1858–1871. doi: 10.1016/j.jsxm.2016.10.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jsxm.2016.10.007</ArticleId>
            <ArticleId IdType="pubmed">27914563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Traish AM, Kim NN, Huang YH, Min K, Munarriz R, Goldstein I. Sex steroid hormones differentially regulate nitric oxide synthase and arginase activities in the proximal and distal rabbit vagina. Int J Impot Res. 2003;15:397–404. doi: 10.1038/sj.ijir.3901097.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.ijir.3901097</ArticleId>
            <ArticleId IdType="pubmed">14671657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim NN, Min K, Pessina MA, Munarriz R, Goldstein I, Traish AM. Effects of ovariectomy and steroid hormones on vaginal smooth muscle contractility. Int J Impot Res. 2004;16:43–50. doi: 10.1038/sj.ijir.3901138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.ijir.3901138</ArticleId>
            <ArticleId IdType="pubmed">14963470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Idris AI. Ovariectomy/orchidectomy in rodents. Methods Mol Biol. 2012;816:545–551. doi: 10.1007/978-1-61779-415-5_34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-61779-415-5_34</ArticleId>
            <ArticleId IdType="pubmed">22130951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang CC, Lee TH, Chang SD. Effects of sex hormones on cell proliferation and apoptosis in the urinary bladder muscle of ovariectomized rat. Taiwan J Obstet Gynecol. 2013;52:335–340. doi: 10.1016/j.tjog.2012.11.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tjog.2012.11.003</ArticleId>
            <ArticleId IdType="pubmed">24075369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dehghan F, Muniandy S, Yusof A, Salleh N. Sex-steroid regulation of relaxin receptor isoforms (RXFP1 &amp; RXFP2) expression in the patellar tendon and lateral collateral ligament of female WKY rats. Int J Med Sci. 2014;11:180–191. doi: 10.7150/ijms.6283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/ijms.6283</ArticleId>
            <ArticleId IdType="pmc">PMC3894403</ArticleId>
            <ArticleId IdType="pubmed">24465164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song X, Zhao P, Wang G, Zhao X. The effects of estrogen and androgen on tear secretion and matrix metalloproteinase-2 expression in lacrimal glands of ovariectomized rats. Invest Ophthalmol Vis Sci. 2014;55:745–751. doi: 10.1167/iovs.12-10457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.12-10457</ArticleId>
            <ArticleId IdType="pubmed">24334444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen O, Rawle F, Peynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Wurbel H. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. doi: 10.1371/journal.pbio.3000410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pbio.3000410</ArticleId>
            <ArticleId IdType="pmc">PMC7360023</ArticleId>
            <ArticleId IdType="pubmed">32663219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giraldi A, Alm P, Werkstrom V, Myllymaki L, Wagner G, Andersson KE. Morphological and functional characterization of a rat vaginal smooth muscle sphrincter. Int J Impot Res. 2002;14:271–282. doi: 10.1038/sj.ijir.3900886.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.ijir.3900886</ArticleId>
            <ArticleId IdType="pubmed">12152117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta C(T)) Method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId>
            <ArticleId IdType="pubmed">11846609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 1978;235(2):E97–E102. doi: 10.1152/ajpendo.1978.235.2.E97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.1978.235.2.E97</ArticleId>
            <ArticleId IdType="pubmed">686171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forsberg JG. A morphologist's approach to the vagina–age-related changes and estrogen sensitivity. Maturitas. 1995;22(Suppl):S7–S15. doi: 10.1016/0378-5122(95)00957-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0378-5122(95)00957-4</ArticleId>
            <ArticleId IdType="pubmed">8775771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park K, Ahn K, Lee S, Ryu S, Park Y, Azadzoi KM. Decreased circulating levels of estrogen alter vaginal and clitoral blood flow and structure in the rabbit. Int J Impot Res. 2001;13:116–124. doi: 10.1038/sj.ijir.3900655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.ijir.3900655</ArticleId>
            <ArticleId IdType="pubmed">11426351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onol FF, Ercan F, Tarcan T. The effect of ovariectomy on rat vaginal tissue contractility and histomorphology. J Sex Med. 2006;3:233–241. doi: 10.1111/j.1743-6109.2006.00216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1743-6109.2006.00216</ArticleId>
            <ArticleId IdType="pubmed">16490016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ballagh SA. Vaginal hormone therapy for urogenital and menopausal symptoms. Semin Reprod Med. 2005;23:26–40. doi: 10.1055/s-2005-869480.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-2005-869480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nappi RE, Lachowsky M. Menopause and sexuality: prevalence of symptoms and impact on quality of life. Maturitas. 2009;63:138–141. doi: 10.1016/j.maturitas.2009.03.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.maturitas.2009.03.021</ArticleId>
            <ArticleId IdType="pubmed">19464129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Traish AM, Kim SW, Stankovic M, Goldstein I, Kim NN. Testosterone increases blood flow and expression of androgen and estrogen receptors in the rat vagina. J Sex Med. 2007;4:609–619. doi: 10.1111/j.1743-6109.2007.00491.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1743-6109.2007.00491.x</ArticleId>
            <ArticleId IdType="pubmed">17498100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pace G, Palumbo P, Miconi G, Silvestri V, Cifone MG, Vicentini C. PDE-5 and NOS II mRNA expression in menopausal women: a molecular biology study. World J Urol. 2011;29:243–248. doi: 10.1007/s00345-010-0517-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00345-010-0517-7</ArticleId>
            <ArticleId IdType="pubmed">20177899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho KJ, Lee KS, Choo MS, Seo JT, Kim JH, Choi JB, Oh SJ, Kim JC. Expressions of vaginal endothelial nitric oxide synthase and phosphodiesterase 5 in female sexual dysfunction: a pilot study. Int Urogynecol J. 2017;28:431–436. doi: 10.1007/s00192-016-3159-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00192-016-3159-5</ArticleId>
            <ArticleId IdType="pubmed">27686568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chivers ML, Rosen RC. Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms? J Sex Med. 2010;7(2 Pt 2):858–872. doi: 10.1111/j.1743-6109.2009.01599.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1743-6109.2009.01599.x</ArticleId>
            <ArticleId IdType="pubmed">19929916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poels S, Bloemers J, van Rooij K, Goldstein I, Gerritsen J, van Ham D, van Mameren F, Chivers M, Everaerd W, Koppeschaar H, Olivier B, Tuiten A. Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues. J Sex Med. 2013;10:810–823. doi: 10.1111/j.1743-6109.2012.02983.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1743-6109.2012.02983.x</ArticleId>
            <ArticleId IdType="pubmed">23130748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bloemers J, Gerritsen J, van Rooij K, de Leede L, van der Geest R, Frijlink HW, Koppeschaar HPF, Olivier B, Tuiten A. The effect of food on the pharmacokinetics of sildenafil after single administration of a sublingual testosterone and oral sildenafil combination tablet in healthy female subjects. J Sex Med. 2019;16:1433–1443. doi: 10.1016/j.jsxm.2019.06.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jsxm.2019.06.015</ArticleId>
            <ArticleId IdType="pubmed">31488289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bertin J, Dury AY, Ouellet J, Pelletier G, Labrie F. Localization of the androgen-synthesizing enzymes, androgen receptor, and sex steroids in the vagina: possible implications for the treatment of postmenopausal sexual dysfunction. J Sex Med. 2014;11:1949–1961. doi: 10.1111/jsm.12589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jsm.12589</ArticleId>
            <ArticleId IdType="pubmed">24919541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maseroli E, Vignozzi L. Testosterone and vaginal function. Sex Med Rev. 2020;8:379–392. doi: 10.1016/j.sxmr.2020.03.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.sxmr.2020.03.003</ArticleId>
            <ArticleId IdType="pubmed">32434695</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
